chr10-114297351-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001001936.3(AFAP1L2):c.2176G>A(p.Glu726Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000726 in 1,613,820 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
NM_001001936.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
AFAP1L2 | NM_001001936.3 | c.2176G>A | p.Glu726Lys | missense_variant | 17/19 | ENST00000304129.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
AFAP1L2 | ENST00000304129.9 | c.2176G>A | p.Glu726Lys | missense_variant | 17/19 | 1 | NM_001001936.3 | P4 | |
AFAP1L2 | ENST00000369271.7 | c.2176G>A | p.Glu726Lys | missense_variant | 17/19 | 1 | A2 | ||
AFAP1L2 | ENST00000696688.1 | c.2260G>A | p.Glu754Lys | missense_variant | 18/20 | A2 | |||
AFAP1L2 | ENST00000491814.1 | n.1298G>A | non_coding_transcript_exon_variant | 5/6 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000493 AC: 75AN: 152212Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000586 AC: 147AN: 250788Hom.: 0 AF XY: 0.000553 AC XY: 75AN XY: 135612
GnomAD4 exome AF: 0.000750 AC: 1096AN: 1461490Hom.: 3 Cov.: 35 AF XY: 0.000710 AC XY: 516AN XY: 727060
GnomAD4 genome AF: 0.000492 AC: 75AN: 152330Hom.: 0 Cov.: 33 AF XY: 0.000510 AC XY: 38AN XY: 74474
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 30, 2021 | The c.2176G>A (p.E726K) alteration is located in exon 17 (coding exon 17) of the AFAP1L2 gene. This alteration results from a G to A substitution at nucleotide position 2176, causing the glutamic acid (E) at amino acid position 726 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at